Gladstone Institutional Advisory LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1766530 Bedminster, NJ

Position in AVXL

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$45,767

-$176,442 QoQ

Shares Held

17,671

-75.6% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#99

of 179 holders

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gladstone Institutional Advisory LLC holds $1,952,269 across 9 Biotechnology names. AVXL ranks #6 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GPCR	Structure Therapeutics Inc.	13,275	$712,469
2	IBRX	ImmunityBio, Inc.	50,818	$444,911
3	VKTX	Viking Therapeutics, Inc.	9,527	$371,648
4	REGN	Regeneron Pharmaceuticals, Inc.	383	$238,815
5	GALT	Galectin Therapeutics Inc	23,900	$110,896
6	AVXL	Anavex Life Sciences Corp. This page	17,671	$45,767
7	CRDF	Cardiff Oncology, Inc.	13,000	$16,900
8	ATYR	aTYR PHARMA INC	11,300	$6,746

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,767	17,671	-75.6%	Shares	Sole	2026-07-27
2026-03-31	$222,209	72,381	+5.7%	Shares	Sole	2026-05-14
2025-12-31	$243,874	68,504	+15.1%	Shares	Sole	2026-02-17
2025-09-30	$529,808	59,529	+19.6%	Shares	Sole	2025-10-22
2025-06-30	$458,833	49,765	+56.4%	Shares	Sole	2025-08-12
2025-03-31	$272,972	31,815	+22.3%	Shares	Sole	2025-05-15
2024-12-31	$279,401	26,015	+44.5%	Shares	Sole	2025-01-29
2023-06-30	$146,340	18,000	-0.9%	Shares	Sole	2023-08-10
2023-03-31	$155,631	18,160	0.0%	Shares	Sole	2023-05-12
2022-12-31	$168,161	18,160	—	Shares	Sole	2023-02-01
No filing history on record for this holder in this stock.